Celyad SA

CYAD Healthcare Biotechnology

Celyad SA’s revenue for fiscal 2025 (year ended December 2025) was $23,800.00, down 88.2% from fiscal 2024.

Market cap
$23.8M
P/E
0.0×
Fwd P/E
−2.3×
Dividend yield
—
F-score
3/9
Altman Z
n/a
Beneish M
10.49
Dividend safety
n/a
Jun '26 Jun '25 Jun '24 Jun '23 Older periods
ROE
0.00% 0.00% 0.00% 0.00%

+8 more TTM periods

ROA
0.00% 0.00% 0.00% 0.00%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
0.00% 0.00% 0.00% 0.00%
Average Days of Receivables
0.00 0.00 0.00 0.00
Free Cash Flow per Share
— 0.00 0.00 0.00
Free Cash Flow
— (28.30) (41.94) (54.44)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 14 Oct 2026